Related Drugs
Compound coenzyme for injection
Indication: It is used for acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia and thrombocytopenia caused by chemotherapy and radiotherapy; it has a certain auxiliary therapeutic effect on oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency. This product is a coenzyme for acetylation reaction, redox reaction and energy metabolism in the human body, and plays an important role in the metabolism of sugar, fat and protein in the body. It is suitable for the treatment of acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia caused by chemotherapy and radiotherapy; it can be used as an auxiliary therapeutic drug for oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Chongqing Kangle Pharmaceutical Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Yaopharma Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Yaopharma Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Shandong Lukang Group Saite Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Cilostazol
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes. 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:
Zhejiang Kinglyuan Pharmaceutical Co., Ltd.
Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:
Zhejiang Deyer Pharmaceutical Co., Ltd.
Cilostazol Tablets
Indication: Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Manufacturer:
Guilin Pharmaceutical Co., Ltd.